Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis

Modern disease-modifying therapies (DMTs) in multiple sclerosis (MS) have variable modes of action and selectively suppress or modulate the immune system. In this review, we summarize the predicted and intended as well as unwanted adverse effects on leukocytes in peripheral blood as a result of trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Schweitzer, F., Laurent, S., Fink, G. R., Barnett, Michael H., Hartung, H. P., Warnke, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217029/
https://www.ncbi.nlm.nih.gov/pubmed/32036423
http://dx.doi.org/10.1007/s00415-019-09690-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217029/
https://www.ncbi.nlm.nih.gov/pubmed/32036423
http://dx.doi.org/10.1007/s00415-019-09690-6

Ejemplares similares